Xenon Pharmaceuticals Inc.

Historical 13F Holders

Symbol
XENE
CUSIP
98420N105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 98420N105 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
11.5% 11/5/2026
Event 9/30/2026
T. Rowe Price Investment Management, Inc. 13G/A 10.3% 11/6/2026
Event 10/31/2026
Avoro Capital Advisors LLC 13G/A
6.3% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G 6.2% 7/17/2025
Event 6/30/2025
Polar Capital Holdings Plc 13G
5.2% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Driehaus Capital Management LLC 13G/A 4.9% 5/15/2026
Event 12/31/2025
Janus Henderson Group PLC 13G/A 4.5% 5/15/2026
Event 3/31/2026
Wellington Management Group LLP 13G/A
1.5% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 292 101 M $3.77B
2026 Q2 319 101 M $6.10B
2026 Q1 297 100 M $5.80B
2025 Q4 254 84.5 M $3.79B
2025 Q3 225 84.3 M $3.39B
2025 Q2 210 83.1 M $2.60B
2025 Q1 214 76.7 M $2.58B
2024 Q4 213 76.3 M $2.99B
2024 Q3 209 74.9 M $2.95B
2024 Q2 216 74.2 M $2.89B
2024 Q1 224 73.5 M $3.16B
2023 Q4 214 72.1 M $3.32B
2023 Q3 185 61.3 M $2.10B
2023 Q2 178 61.3 M $2.36B
2023 Q1 168 61.1 M $2.19B
2022 Q4 163 60.5 M $2.38B
2022 Q3 156 57.9 M $2.09B
2022 Q2 153 57.0 M $1.73B
2022 Q1 138 49.2 M $1.51B
2021 Q4 133 47.7 M $1.49B
2021 Q3 123 34.1 M $522M
2021 Q2 104 33.6 M $671M
2021 Q1 93 33.0 M $590M
2020 Q4 82 28.0 M $431M
2020 Q3 80 27.9 M $309M
2020 Q2 80 28.0 M $351M
2020 Q1 71 27.7 M $314M
2019 Q4 67 18.7 M $245M
2019 Q3 54 16.1 M $145M
2019 Q2 60 17.6 M $173M
2019 Q1 63 17.7 M $180M
2018 Q4 59 17.5 M $110M
2018 Q3 61 17.7 M $235M
2018 Q2 42 9.24 M $84.7M
2018 Q1 35 6.35 M $31.1M
2017 Q4 32 9.16 M $25.9M
2017 Q3 31 9.32 M $27.5M
2017 Q2 39 9.95 M $31.3M
2017 Q1 38 10.1 M $40.3M
2016 Q4 31 10.5 M $80.8M
2016 Q3 31 9.94 M $80.6M
2016 Q2 21 5.38 M $32.0M
2016 Q1 25 5.71 M $39.9M
2015 Q4 25 5.78 M $46.5M
2015 Q3 25 5.48 M $45.2M
2015 Q2 26 4.81 M $55.4M
2015 Q1 23 4.45 M $75.2M
2014 Q4 17 4.28 M $83.1M